Your browser doesn't support javascript.
loading
Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis.
Guillen-Guio, Beatriz; Paynton, Megan L; Allen, Richard J; Chin, Daniel P W; Donoghue, Lauren J; Stockwell, Amy; Leavy, Olivia C; Hernandez-Beeftink, Tamara; Reynolds, Carl; Cullinan, Paul; Martinez, Fernando; Booth, Helen L; Fahy, William A; Hall, Ian P; Hart, Simon P; Hill, Mike R; Hirani, Nik; Hubbard, Richard B; McAnulty, Robin J; Millar, Ann B; Navaratnam, Vidya; Oballa, Eunice; Parfrey, Helen; Saini, Gauri; Sayers, Ian; Tobin, Martin D; Whyte, Moira K B; Adegunsoye, Ayodeji; Kaminski, Naftali; Shwu-Fan, Ma; Strek, Mary E; Zhang, Yingze; Fingerlin, Tasha E; Molina-Molina, Maria; Neighbors, Margaret; Sheng, X Rebecca; Oldham, Justin M; Maher, Toby M; Molyneaux, Philip L; Flores, Carlos; Noth, Imre; Schwartz, David A; Yaspan, Brian L; Jenkins, R Gisli; Wain, Louise V; Hollox, Edward J.
  • Guillen-Guio B; Department of Population Health Sciences, University of Leicester, UK.
  • Paynton ML; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Allen RJ; Department of Population Health Sciences, University of Leicester, UK.
  • Chin DPW; Department of Population Health Sciences, University of Leicester, UK.
  • Donoghue LJ; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Stockwell A; Department of Population Health Sciences, University of Leicester, UK.
  • Leavy OC; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Hernandez-Beeftink T; Genentech, California, USA.
  • Reynolds C; Genentech, California, USA.
  • Cullinan P; Department of Population Health Sciences, University of Leicester, UK.
  • Martinez F; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Booth HL; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Fahy WA; Imperial College London, London, UK.
  • Hall IP; Imperial College London, London, UK.
  • Hart SP; Weill Cornell Medicine, New York, USA.
  • Hirani N; University College London Hospitals, London, UK.
  • Hubbard RB; GlaxoSmithKline, London, UK.
  • McAnulty RJ; University of Nottingham, Nottingham, UK.
  • Millar AB; National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK.
  • Navaratnam V; University of Hull, Hull, UK.
  • Oballa E; University of Oxford, Oxford, UK.
  • Parfrey H; University of Edinburgh, Edinburgh, UK.
  • Saini G; University of Nottingham, Nottingham, UK.
  • Sayers I; National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK.
  • Tobin MD; University College London, London, UK.
  • Whyte MKB; University of Bristol, Bristol, UK.
  • Adegunsoye A; Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.
  • Kaminski N; National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Shwu-Fan M; Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, QLD, Australia.
  • Strek ME; GlaxoSmithKline, London, UK.
  • Zhang Y; Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
  • Fingerlin TE; University of Nottingham, Nottingham, UK.
  • Molina-Molina M; Centre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK.
  • Neighbors M; Department of Population Health Sciences, University of Leicester, UK.
  • Sheng XR; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Oldham JM; University of Edinburgh, Edinburgh, UK.
  • Maher TM; University of Chicago, Chicago, USA.
  • Molyneaux PL; Yale School of Medicine, Connecticut, USA.
  • Flores C; University of Virginia, Virginia, USA.
  • Noth I; University of Chicago, Chicago, USA.
  • Schwartz DA; University of Pittsburgh, Pittsburgh, USA.
  • Yaspan BL; National Jewish Health, Colorado, USA.
  • Jenkins RG; Servei de Pneumologia, Laboratori de Pneumologia Experimental, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.
  • Wain LV; Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain.
  • Hollox EJ; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
medRxiv ; 2023 Jul 24.
Article en En | MEDLINE | ID: mdl-37546732
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the pathogenesis of IPF and a prior association of the HLA-DQB1 gene with idiopathic fibrotic interstitial pneumonia (including IPF) has been reported. Due to the important role that the Human Leukocyte Antigen (HLA) region plays in the immune response, here we evaluated if HLA genetic variation was associated specifically with IPF risk. Methods: We performed a meta-analysis of associations of the HLA region with IPF risk in individuals of European ancestry from seven independent case-control studies of IPF (comprising a total of 5,159 cases and 27,459 controls, including the prior study of fibrotic interstitial pneumonia). Single nucleotide polymorphisms, classical HLA alleles and amino acids were analysed and signals meeting a region-wide association threshold p<4.5×10-4 and a posterior probability of replication >90% were considered significant. We sought to replicate the previously reported HLA-DQB1 association in the subset of studies independent of the original report. Results: The meta-analysis of all seven studies identified four significant independent single nucleotide polymorphisms associated with IPF risk. However, none met the posterior probability for replication criterion. The HLA-DQB1 association was not replicated in the independent IPF studies. Conclusion: Variation in the HLA region was not consistently associated with risk in studies of IPF. However, this does not preclude the possibility that other genomic regions linked to the immune response may be involved in the aetiology of IPF.

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article